SINGAPORE, 1 OCTOBER 2026 —It’s one of the biggest mysteries of age-related research: despite living longer, women are more likely than men to develop age and immune-related conditions, yet the biological reasons behind these differences remain poorly understood.
Scientists at Duke-NUS Medical School have shed new light on this by integrating and analysing large-scale immune-cell datasets to uncover how healthy immune cells change differently in men and women as they age. These findings, recently published in Nature Communications , pave the way for more personalised treatments for age and immune-related diseases, taking into account a patient’s sex and age.
More than 600,000 people in Singapore, or about 11 per cent of the population, suffer from autoimmune diseases such as lupus and rheumatoid arthritis [1] . These are conditions where the immune system turns against itself and attacks the body’s major organs. Autoimmune conditions are strongly related to both age and sex.
The scientists found that the immune cells circulating in our bloodstream do not age at a steady pace. Instead, they undergo periods of accelerated ageing, with major shifts in gene activity occurring around age 40 and again after 60. The analyses showed that the fundamental machinery behind cell function (i.e. genes responsible for synthesis of RNA and proteins) decline most at these two ageing peak points.
The authors studied how each immune cell type ages in men and women across a heathy lifespan. They found that T cells, a type of white blood cell that helps our immune system fight germs, showed the most pronounced changes in gene activity around people’s 40s. This reflects their central role in coordinating the body’s immune response and their sensitivity to the effects of ageing.
T cells were also predominantly found to be the main drivers of a second wave of changes after age 60. Interestingly, the type of T cells that change profoundly at 40s and 60s is different, suggesting their specialised roles at different stages of life. In addition, the way these specialised T cells change their activity throughout life show differences between men and women.
“We tend to think of ageing as a gradual process, but our findings show that the immune system does not simply decline at a steady rate. Instead, we see distinct periods of rapid change, particularly around 40 and again after 60, with T cells playing a major role. Understanding what drives these windows of immune ageing could eventually help us identify when, and for whom, interventions may have the greatest benefit. It could also shed light on why some autoimmune conditions disproportionately affect women,” explained senior author of the study, Associate Professor Jacques Behmoaras , from the Centre of Biomedical Data Science at Duke-NUS Medical School.
One of the largest and most diverse of its kind, the study examined the genetic activity of 3.8 million individual immune cells from nearly 2,000 healthy people aged 19 to 97. Among these people were those of Asian ethnicity, including Singaporeans. The cell data was collated from various publicly available research datasets and integrated to create an immune atlas.
“Our findings build on previous evidence that T cells are among the immune cells most affected by ageing. Understanding what drives these nonlinear changes in T cells over time will be an important next step. Changes in T cell function may help explain why older adults are more susceptible to infections and inflammatory conditions,” said Professor Antonio Bertoletti from the Emerging Infectious Diseases Signature Research Programme in Duke-NUS Medical School, who is one of the authors of the study.
The study was conducted at Duke-NUS’ Centre of Biomedical Data Science in collaboration with the school’s Signature Research Programmes in Cardiovascular and Metabolic Disorders, Cancer and Stem Cell Biology, and Emerging Infectious Diseases. The research also involved partners from NUS Yong Loo Lin School of Medicine.
“The study gives us a more detailed map of how the human immune system changes across the lifespan, and importantly, how those trajectories differ between men and women. That knowledge is fundamental if we want to move away from treating ageing as a one-size-fits-all approach and move towards more precise approaches to maintaining health as people grow older,” said Professor Sheemei Lok , Duke-NUS’ Interim Vice-Dean for Research.
The scientists used the study data to build AI models that would predict biological age—an estimation of the ‘true age’ of the human body that may differ from one’s actual age. With this tool, the scientists hope to do more research on specific biological pathways and time windows where interventions could be tailored by sex.
This research was supported by the National Research Foundation, Singapore (NRF) under the National Medical Research Council (NMRC) Open Fund-Large Collaborative Grant (MOH-001327) and Open Fund-Individual Research Grant (MOH-001622) and administered by the Singapore Ministry of Health through the NMRC Office, MOH Holdings Pte Ltd, Ministry of Education Singapore (MOE-T2EP30125-0010 to J.B.), Agency for Science and Technology (Industry Alignment Fund Prepositioning grant, H24J4a0019 to J.B.) and Duke-NUS.
###
DOI: 10.1038/s41467-026-76737-4
[1] https://www.healthxchange.sg/how-to-manage/rheumatoid-arthritis/rheumatological-diseases-in-singapore
About Duke-NUS Medical School
Duke-NUS is Singapore’s flagship graduate entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted ‘Clinicians Plus’ poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five Signature Research Programmes and ten Centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore’s largest healthcare group. This strategic alliance has led to the creation of 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives.
For more information, please visit www.duke-nus.edu.sg
About the National Medical Research Council (NMRC)
The NMRC was established in 1994 to oversee research funding from the Ministry of Health and support the development and advancement of biomedical research in Singapore, particularly in the public healthcare clusters and medical schools. NMRC engages in research strategy and planning, provides funding to support competitive research grants and core research enablers, and is responsible for the development of clinician scientists through awards and fellowships. The council’s work is supported by the NMRC Office which is part of MOH Holdings Pte Ltd. Through its management of the various funding initiatives, NMRC promotes healthcare research in Singapore, for better health and economic outcomes.
About the National Research Foundation (NRF)
The National Research Foundation, Singapore (NRF), set up on 1 January 2006, is a department within the Prime Minister’s Office. The NRF sets the national direction for research and development (R&D) by developing policies, plans and strategies for research, innovation and enterprise. It also funds strategic initiatives and builds up R&D capabilities by nurturing research talent. Learn more about the NRF at www.nrf.gov.sg .
Nature Communications
Meta-analysis
Cells
Sex-specific trajectories of nonlinear immune aging at single-cell level
21-Aug-2026